Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer's disease dementia with high accuracy in an African American cohort
Lindsey A. Kuchenbecker, Kevin J. Thompson, Cheyenne D. Hurst…·Minerva M. Carrasquillo
Author
Emory UniversityORCID 0000-0003-0418-249XUnclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Lindsey A. Kuchenbecker, Kevin J. Thompson, Cheyenne D. Hurst…·Minerva M. Carrasquillo
Cheyenne D. Hurst, Amy R. Dunn, Eric B. Dammer…·Erik C. B. Johnson
This study shows genetic background affects the proteome in 5XFAD AD mouse models, with some disease-related modules influenced by genetic background while others are not.
Nicholas H. Harbin, Daniel J. Lustberg, Cheyenne D. Hurst…·John R. Hepler
This study shows RGS14 protects hippocampal neurons from seizure-induced mitochondrial oxidative stress and pathology by modulating excitability and signaling.
Cheyenne D. Hurst, Derian A. Pugh, Measho H. Abreha…·Nicholas T. Seyfried
The paper identifies NRN1 as a mediator of cognitive resilience to Alzheimer's disease through integrative proteomic analysis and functional validation in neurons.
Lenora A. Higginbotham, Lingyan Ping, Eric B. Dammer…·Nicholas T. Seyfried
The paper identifies brain-linked CSF biomarkers in Alzheimer’s disease using proteomics, revealing altered levels in both brain and CSF across different disease stages.